Holen Sie sich die Stockscreener-App
43.78
0.39%
0.23
Schlusskurs vom Vortag:
$43.55
Offen:
$44
24-Stunden-Volumen:
670.39K
Relative Volume:
1.51
Marktkapitalisierung:
$1.96B
Einnahmen:
$1.15B
Nettoeinkommen (Verlust:
$23.09M
KGV:
87.56
EPS:
0.5
Netto-Cashflow:
$89.18M
1W Leistung:
+13.68%
1M Leistung:
+22.53%
6M Leistung:
+38.01%
1J Leistung:
-7.18%
1-Tages-Spanne:
$43.38
$45.36
1-Wochen-Bereich:
$38.31
$45.36
52-Wochen-Spanne:
$22.66
$47.70
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
43.78 | 1.95B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
232.04 | 39.30B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.28 | 13.71B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.62 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.25 | 7.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.34 | 6.23B | 11.99B | 24.18M | 234.31M | 0.2956 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Benchmark raises Omnicell stock price target to $50 on new Titan XT system - Investing.com UK
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Omnicell stock rises after launch of enterprise-level medication dispensing system - Investing.com Nigeria
Omnicell Launches Advanced Titan XT Dispensing System - TipRanks
Omnicell launches Titan XT automated dispensing system for hospitals By Investing.com - Investing.com South Africa
Omnicell, Inc. Launches Omnicell Titan XT Automated Dispensing System - TradingView
Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management - Yahoo Finance
Omnicell (OMCL) Valuation Check After Recent Share Price Rebound - Yahoo Finance
1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off - Markets Financial Content
Insider Sell: Corey Manley Sells Shares of Omnicell Inc (OMCL) - GuruFocus
Omnicell EVP & Chief Legal/Admin Officer Sells Shares - TradingView
Reasons to Add Omnicell Stock to Your Portfolio Right Now - Nasdaq
Why Omnicell Inc. (OC9) stock is favored by hedge fundsForecast Cut & Real-Time Volume Spike Alerts - Newser
Will Omnicell Inc. stock outperform tech sector in 2025Trade Volume Summary & Fast Moving Market Watchlists - Newser
Why Omnicell Inc stock could rally in 2025Market Performance Recap & Verified Short-Term Trading Plans - BỘ NỘI VỤ
Is Omnicell Inc. (OC9) stock undervalued at current price2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Is Omnicell Inc. (OC9) stock a good hedge against inflationTrade Analysis Report & Verified Swing Trading Watchlist - Newser
Why Omnicell Inc. (OC9) stock stays resilient2025 Price Momentum & Weekly High Return Stock Forecasts - Newser
Systematic Financial Management LP Acquires New Stake in Omnicell, Inc. $OMCL - MarketBeat
Will Omnicell Inc. (OC9) stock sustain uptrend momentum2025 Investor Takeaways & Verified Momentum Stock Alerts - Newser
Prudential Financial Inc. Cuts Stock Position in Omnicell, Inc. $OMCL - MarketBeat
VP Manley Files To Sell 6,106 Of Omnicell Inc [OMCL] - TradingView
Omnicell Chairman and CEO Randall A. Lipps Sells 28,250 Shares - TradingView
How Omnicell Inc. (OC9) stock gains from tech spendingDollar Strength & High Return Trade Opportunity Guides - Newser
Will Omnicell Inc. (OC9) stock keep raising dividendsWeekly Volume Report & Weekly Breakout Opportunity Watchlist - Newser
With Omnicell Stock Surging, Have You Considered The Downside? - Trefis
Aug Swings: Why Omnicell Inc stock could rally in 2025July 2025 Short Interest & Reliable Trade Execution Plans - BỘ NỘI VỤ
Will Omnicell Inc. (OC9) stock beat Nasdaq index returns2025 Investor Takeaways & Safe Investment Capital Preservation Plans - Newser
Will Omnicell Inc. (OC9) stock deliver compounding returns2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Is Omnicell Inc. (OC9) stock trading at attractive multiplesBull Run & Technical Pattern Recognition Alerts - Newser
OMCL6251486 Bond Price and Chart — FINRA:OMCL6251486 - TradingView
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show - Business Wire
Omnicell (OMCL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Chmn Lipps Files To Sell 28,250 Of Omnicell Inc [OMCL] - TradingView
Omnicell, Inc. $OMCL Shares Bought by Martin & Co. Inc. TN - MarketBeat
Market Wrap: Is Omnicell Inc. stock a top pick in earnings season2025 Earnings Impact & Accurate Technical Buy Alerts - BỘ NỘI VỤ
Omnicell Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Will Omnicell Inc. stock attract more institutional investors2025 Investor Takeaways & Community Shared Stock Ideas - BỘ NỘI VỤ
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL) - Yahoo Finance
What Omnicell (OMCL)'s Upward Earnings Estimate Revisions Mean For Shareholders - Sahm
Rockefeller Capital Management L.P. Reduces Stock Position in Omnicell, Inc. $OMCL - MarketBeat
Wall Street Analysts Think Omnicell (OMCL) Could Surge 30.93%: Read This Before Placing a Bet - sharewise.com
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Omnicell Outpaces Expectations With Strong Q3 Growth And Upgrades - Finimize
Q3 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
What analysts say about Omnicell Inc OC9 stockRelative Strength Index (RSI) & Budget Friendly Trading Strategies - earlytimes.in
Omnicell appoints Baird Radford as Executive VP and CFO - MSN
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know - Finviz
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):